Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-α production in a receptor for advanced glycation end product-dependent manner

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 4213-4222

  Ruan, Benfang Helen ^a   Li, Xin ^a   Winkler, Aaron R ^a   Cunningham, Kristina M ^a   Kuai, Jun ^a   Greco, Rita M ^a   Nocka, Karl H ^a   Fitz, Lori J ^a   Wright, Jill F ^a   Pittman, Debra D ^a   Tan, Xiang Yang ^a   Paulsen, Janet E ^a   Lin, Lih Ling ^a   Winkler, David G ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA INTERFERON; COMPLEMENT COMPONENT C3A; CPG OLIGODEOXYNUCLEOTIDE; DNA; HIGH MOBILITY GROUP B1 PROTEIN; GAMMA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; OLIGONUCLEOTIDE; RAGE PROTEIN, HUMAN; TUMOR ANTIGEN;

ANIMAL CELL; ANISOTROPY; ARTICLE; AUTOIMMUNE DISEASE; BINDING AFFINITY; BONE MARROW CELL; COMPLEMENT FIXATION; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; WILD TYPE; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PROTEIN BINDING;

ANIMALS; ANTIGENS, NEOPLASM; COMPLEMENT C3A; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERFERON-GAMMA; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDES; PROTEIN BINDING; SURFACE PLASMON RESONANCE;

EID: 77958136728     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000863     Document Type: Article

References (41)

1. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97:889-901.
2. Tian, J., A. M. Avalos, S. Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, C. Sirois, et al. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487-496.
3. Boulanger, E., M. P. Wautier, J. L. Wautier, B. Boval, Y. Panis, N. Wernert, P. M. Danze, and P. Dequiedt. 2002. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int. 61:148-156.
4. Pullerits, R., M. Brisslert, I. M. Jonsson, and A. Tarkowski. 2006. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via b2 integrin Mac-1. Arthritis Rheum. 54:3898-3907.
5. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-b peptide neulrotoxicity in Alzheimer's disease. Nature 382:685-691.
6. Nienhuis, H. L., J. Westra, A. J. Smit, P. C. Limburg, C. G. Kallenberg, and M. Bijl. 2009. AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity 42:302-304.
7. Hofmann, M. A., S. Drury, B. I. Hudson, M. R. Gleason, W. Qu, Y. Lu, E. Lalla, S. Chitnis, J. Monteiro, M. H. Stickland, et al. 2002. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3:123-135.
8. Liliensiek, B., M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, S. Hofer, J. Plachky, H. J. Grone, F. C. Kurschus, A. M. Schmidt, et al. 2004. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113:1641-1650.
9. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358:929-939.
10. Koffler, D., P. H. Schur, and H. G. Kunkel. 1967. Immunological studies concerning the nephritis of systemic lupus erythematosus. J. Exp. Med. 126:607-624.
11. Grootscholten, C., M. C. van Bruggen, J. W. van der Pijl, E. M. de Jong, G. Ligtenberg, R. H. Derksen, and J. H. Berden. 2003. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum. 48:1355-1362.
12. Mannik, M., C. E. Merrill, L. D. Stamps, and M. H. Wener. 2003. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J. Rheumatol. 30:1495-1504.
13. Kowal, C., L. A. Degiorgio, J. Y. Lee, M. A. Edgar, P. T. Huerta, B. T. Volpe, and B. Diamond. 2006. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. USA 103:19854-19859.
14. Denny, M. F., P. Chandaroy, P. D. Killen, R. Caricchio, E. E. Lewis, B. C. Richardson, K. D. Lee, J. Gavalchin, and M. J. Kaplan. 2006. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J. Immunol. 176:2095-2104.
15. Kramers, C., M. N. Hylkema, M. C. van Bruggen, R. van de Lagemaat, H. B. Dijkman, K. J. Assmann, R. J. Smeenk, and J. H. Berden. 1994. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J. Clin. Invest. 94:568-577.
16. Jiang, W., and D. S. Pisetsky. 2008. Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus. Ann. Rheum. Dis. 67:727-728.
17. Porcel, J. M., J. Ordi, A. Castro-Salomo, M. Vilardell, M. J. Rodrigo, T. Gene, F. Warburton, M. Kraus, and D. Vergani. 1995. The value of complement activation products in the assessment of systemic lupus erythematosus flares. Clin. Immunol. Immunopathol. 74:283-288.
18. Bengtsson, A. A., G. Sturfelt, L. Truedsson, J. Blomberg, G. Alm, H. Vallin, and L. Ronnblom. 2000. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9:664-671.
19. Chen, J. A., S. Meister, V. Urbonaviciute, F. Rodel, S. Wilhelm, J. R. Kalden, K. Manger, and R. E. Voll. 2007. Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus. Autoimmunity 40:307-310.
20. Bave, U., M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, and L. Ronnblom. 2003. FcgRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171:3296-3302.
21. Ronnblom, L., and G. V. Alm. 2003. Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 5:68-75.
22. Wang, Q., M. Zeng, W. Wang, and J. Tang. 2007. The HMGB1 acidic tail regulates HMGB1 DNA binding specificity by a unique mechanism. Biochem. Biophys. Res. Commun. 360:14-19.
23. Urbonaviciute, V., B. G. Furnrohr, S. Meister, L. Munoz, P. Heyder, F. De Marchis, M. E. Bianchi, C. Kirschning, H. Wagner, A. A. Manfredi, et al. 2008. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205:3007-3018.
24. Yanai, H., T. Ban, Z. Wang, M. K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, R. Koshiba, et al. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99-103.
25. Popovic, P. J., R. De Marco, M. T. Lotze, S. E. Winikoff, D. L. Bartlett, A. M. Krieg, Z. S. Guo, C. K. Brown, K. J. Tracey, and H. J. Zeh, III. 2006. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. J. Immunol. 177:8701-8707.
26. Lutterloh, E. C., and S. M. Opal. 2007. Antibodies against RAGE in sepsis and inflammation: implications for therapy. Expert Opin. Pharmacother. 8:1193-1196.
27. Wu, C. C., J. Lee, E. Raz, M. Corr, and D. A. Carson. 2004. Necessity of oligonucleotide aggregation for Toll-like receptor 9 activation. J. Biol. Chem. 279:33071-33078.
28. Houssiau, F. A., C. Lefebvre, M. Vanden Berghe, M. Lambert, J. P. Devogelaer, and J. C. Renauld. 1995. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4:393-395.
29. Fabian, D., A. Bukovska, S. Juhas, and J. Koppel. 2009. Apoptotic processes and DNA cytosine methylation in mouse embryos arrested at the 2-cell stage. Zygote 17:269-279.
30. Su, K. Y., and D. S. Pisetsky. 2009. The role of extracellular DNA in autoimmunity in SLE. Scand. J. Immunol. 70:175-183.
31. Jozefowski, S., T. H. Sulahian, M. Arredouani, and L. Kobzik. 2006. Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J. Leukoc. Biol. 80:870-879.
32. Walport, M. J. 2002. Complement and systemic lupus erythematosus. Arthritis Res. 4 (Suppl. 3): S279-S293.
33. Taylor, P. R., A. Carugati, V. A. Fadok, H. T. Cook, M. Andrews, M. C. Carroll, J. S. Savill, P. M. Henson, M. Botto, and M. J. Walport. 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192:359-366.
34. Ferry, H., P. K. Potter, T. L. Crockford, A. Nijnik, M. R. Ehrenstein, M. J. Walport, M. Botto, and R. J. Cornall. 2007. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J. Immunol. 178:2916-2922.
35. Peng, Q., K. Li, S. H. Sacks, and W. Zhou. 2009. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses. Inflamm. Allergy Drug Targets 8:236-246.
36. Hartmann, K., B. M. Henz, S. Kruger-Krasagakes, J. Kohl, R. Burger, S. Guhl, I. Haase, U. Lippert, and T. Zuberbier. 1997. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89:2863-2870.
37. Zhang, X., Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J. D. Lambris, R. A. Wetsel, T. Miwa, and W. C. Song. 2007. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110:228-236.
38. Ramasamy, R., S. F. Yan, and A. M. Schmidt. 2009. RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts. J. Leukoc. Biol. 86:505-512.
39. Tanji, N., G. S. Markowitz, C. Fu, T. Kislinger, A. Taguchi, M. Pischetsrieder, D. Stern, A. M. Schmidt, and V. D. D'Agati. 2000. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J. Am. Soc. Nephrol. 11:1656-1666.
40. Nienhuis, H. L., K. de Leeuw, J. Bijzet, A. Smit, C. G. Schalkwijk, R. Graaff, C. G. Kallenberg, and M. Bijl. 2008. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation end products. Rheumatology 47:1554-1558.
41. Maillard-Lefebvre, H., E. Boulanger, M. Daroux, C. Gaxatte, B. I. Hudson, and M. Lambert. 2009. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology 48:1190-1196.